Your browser doesn't support javascript.
loading
HER2 Heterogeneity Is Associated with Poor Survival in HER2-Positive Breast Cancer.
Hosonaga, Mari; Arima, Yoshimi; Sampetrean, Oltea; Komura, Daisuke; Koya, Ikuko; Sasaki, Takashi; Sato, Eiichi; Okano, Hideyuki; Kudoh, Jun; Ishikawa, Shumpei; Saya, Hideyuki; Ishikawa, Takashi.
Afiliação
  • Hosonaga M; Department of Breast Surgery and Oncology, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo 160-0023, Japan. mariachi@tokyo-med.ac.jp.
  • Arima Y; Division of Gene Regulation, Institute for Advanced Medical Research, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan. arima@z7.keio.jp.
  • Sampetrean O; Division of Gene Regulation, Institute for Advanced Medical Research, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan. oltea@a6.keio.jp.
  • Komura D; Department of Genomic Pathology, Medical Research Institute, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8510, Japan. komura-daisuke@umin.ac.jp.
  • Koya I; Department of Physiology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan. koya-ikuko@a5.keio.jp.
  • Sasaki T; Center for Supercentenarian Medical Research, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan. sasasa@z5.keio.jp.
  • Sato E; Department of Pathology (Medical Research Center), Institute of Medical Science, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo 160-0023, Japan. sato-e@tokyo-med.ac.jp.
  • Okano H; Department of Physiology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan. hidokano@a2.keio.jp.
  • Kudoh J; Laboratory of Gene Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan. jkudoh@dmb.med.keio.ac.jp.
  • Ishikawa S; Department of Genomic Pathology, Medical Research Institute, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8510, Japan. sish.gpat@mri.tmd.ac.jp.
  • Saya H; Division of Gene Regulation, Institute for Advanced Medical Research, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan. hsaya@a5.keio.jp.
  • Ishikawa T; Department of Breast Surgery and Oncology, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo 160-0023, Japan. tishik@gmail.com.
Int J Mol Sci ; 19(8)2018 Jul 24.
Article em En | MEDLINE | ID: mdl-30042341
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptor ErbB-2 / Heterogeneidade Genética Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals / Female / Humans Idioma: En Revista: Int J Mol Sci Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptor ErbB-2 / Heterogeneidade Genética Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals / Female / Humans Idioma: En Revista: Int J Mol Sci Ano de publicação: 2018 Tipo de documento: Article